SCHEDULE 13G/A: Wellington Management Group Discloses 7.46% Stake in Akero Therapeutics

Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, disclosing a beneficial ownership of 7.46% in Akero Therapeutics, Inc. common stock as of March 31, 2025.

Summary

• Wellington Management Group LLP, along with its affiliates Wellington Group Holdings LLP, Wellington Investment Advisors Holdings LLP, and Wellington Management Company LLP, collectively reported beneficial ownership of 5,936,240 shares of Akero Therapeutics, Inc. common stock.
• This aggregate ownership represents 7.46% of Akero Therapeutics, Inc.'s common stock.
• The filing is an Amendment No. 3 to a previously filed Schedule 13G, indicating an update to their ownership position.
• The beneficial ownership is primarily held through shared voting power of 5,447,579 shares and shared dispositive power of 5,936,240 shares by the Wellington entities.
• The securities are owned of record by clients of the Wellington Investment Advisers, and no single client is known to have beneficial ownership of more than five percent of the class of securities.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership, providing neutral information without positive or negative implications for the company's performance or outlook.

Future Outlook

NA

Industry Context

This filing reflects a routine disclosure by a major investment management firm, Wellington Management Group, regarding its passive ownership stake in a biotechnology company, Akero Therapeutics. Such disclosures are common for institutional investors holding significant positions and provide transparency into major shareholder bases within the industry.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake in the company, which can influence market perception and liquidity.

Key Dates

Keywords

Akero Therapeutics, Wellington Management Group, Schedule 13G, beneficial ownership, common stock, investment management, institutional ownership, SEC filing